SeqOne is excited to join leading hematologists, oncologists, and laboratory specialists at Hemato 2026 in Bilbao, Spain.

As Spain's premier national gathering for clinical hematology and thrombosis research, the congress unites clinicians, scientific researchers, and biotech innovators to advance patient care across malignant and non-malignant blood disorders.

Key Themes:

  • Onco-Hematology & Precision Diagnostics: Leveraging Next-Generation Sequencing (NGS) and AI-driven bioinformatic pipelines to improve risk stratification, minimal residual disease (MRD) monitoring, and targeted therapies in hematologic malignancies.
  • Hemostasis, Thrombosis & Vascular Biology: Discovering novel genomic markers and cellular mechanisms to refine diagnostic workflows for bleeding disorders and thrombotic risks.
  • Translational Genomics & Cell Therapy: Integrating multi-omics, somatic variant interpretation, and advanced cell therapies into routine clinical laboratory practice.

‍

🧬 Experience the platform at Hemato 2026

  • One NGS Platform, Built for Scale: End-to-end interpretation workflow with broad wet lab and sequencer compatibility.
  • AI Precision for Clinical Workflows: Built for real-world labs, SeqOne delivers fast, actionable insights, helping your team spend less time on variant interpretation and more time on confident clinical decisions.
  • Evaluate SeqOne for yourself: Visit our booth to explore our latest resources and learn how to start a free 30-day trial using your own data.

‍

👋 Meet the SeqOne Team

In town for the event? Let's connect! We’re booking 1-on-1 sessions to discuss whatever is top of mind for your team, from scientific collaborations and business inquiries to live walkthroughs of our NGS platform.

‍

Natalia Giner Laguarda
Account Executive, Spain & Latin America
👉Book a Meeting

‍